mitomycin 10mg powder for solution for injection/infusion or intravesical use
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - mitomycin - powder for solution for injection/infusion - mitomycin 10 mg - antineoplastic agents
mitomycin 2mg powder for solution for injection/infusion or intravesical use
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - mitomycin - powder for solution for injection/infusion - mitomycin 2 mg - antineoplastic agents
mitomycin-c-kyowa
bristol-myers squibb (nz) limited - mitomycin 10mg (mitomycin-c) - powder for injection - 10 mg - active: mitomycin 10mg (mitomycin-c) excipient: sodium chloride
mitomycin-c-kyowa
bristol-myers squibb (nz) limited - mitomycin 20mg (mitomycin-c) - powder for injection - 20 mg - active: mitomycin 20mg (mitomycin-c) excipient: sodium chloride
mitomycin-c-kyowa
bristol-myers squibb (nz) limited - mitomycin 2mg (mitomycin-c) - powder for injection - 2 mg - active: mitomycin 2mg (mitomycin-c) excipient: sodium chloride
mitomycin medac 20 mg powder and solvent for intravesical solution
medac gesellschaft fur klinische spezialpraparate mbh - mitomycin - pdr+solv/soln/intravesical use - 20 milligram(s) - other cytotoxic antibiotics; mitomycin
mitomycin medac 40 mg powder and solvent for intravesical solution
medac gesellschaft für klinische spezialpräparate mbh - mitomycin - powder and solvent for intravesical solution - 40 milligram(s) - other cytotoxic antibiotics; mitomycin
mitomycin c 10 mg
dexcel ltd, israel - mitomycin c (crystalline) - powder for solution for injection - mitomycin c (crystalline) 10 mg/vial - mitomycin - mitomycin - remission of subjective and objective symptoms assocciated with the following diseases: - chronic lymphocytic leukemia, - chronic myelocytic leukemia, - gastric cancer, - colorectal cancer, - lung cancer, - pancreatic cancer, - liver cancer, - cervix cancer, - cancer of the endometrium, - breast cancer, - head and neck tumor, - bladder tumor.
mitomycin c 2 mg
dexcel ltd, israel - mitomycin c ( crystalline ) - powder for solution for injection - mitomycin c ( crystalline ) 2 mg/vial - mitomycin - mitomycin - remission of subjective and objective symptoms assocciated with the following diseases: chronic lymphocytic leukemia, chronic myelocytic leukemia, gastric cancer, colorectal cancer, lung cancer, pancreatic cancer, liver cancer, cervix cancer, cancer of the endometrium, breast cancer, head and neck tumor and bladder tumor.
mitomycin for injection
teva pharma (new zealand) limited - mitomycin 20mg; - powder for injection - 20 mg - active: mitomycin 20mg excipient: mannitol - mitomycin for injection usp is not recommended as single-agent, primary therapy. it has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. mitomycin for injection usp is not recommended to replace appropriate surgery and/or radiotherapy.